GlassScriptPhysician profile
Karen T Jordan
NPI 1447211941
$1,046.27
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $190 · 2021: $156.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $218.72 | 2019-2021 | |
| Abbvie INC. | $197.62 | 2019-2021 | |
| Janssen Biotech, INC. | $104.43 | 2019-2021 | |
| Genentech USA, INC. | $98.04 | 2019 | |
| Vyne Pharmaceuticals INC. | $68.36 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $54.13 | 2019-2021 | |
| Journey Medical Corporation | $46.90 | 2019 | |
| Encore Dermatology INC. | $45.91 | 2019 | |
| Organogenesis INC. | $34.26 | 2019 | |
| Galderma Laboratories, L.P. | $32.86 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $22.94 | 2019 | |
| Genzyme Corporation | $22.48 | 2019 | |
| Almirall LLC | $19.55 | 2019 | |
| Dusa Pharmaceuticals, INC. | $17.39 | 2019 | |
| Sensus Healthcare, INC. | $15.91 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $14.19 | 2019 | |
| Mayne Pharma Commercial LLC | $12.31 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $10.98 | 2019 | |
| Prugen, INC. Pharmaceuticals | $9.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.